Abstract
Background
Kidney transplantation is the optimal treatment for end-stage renal disease; however, the limited availability of donor kidneys hinders the advancement of this procedure. The utilisation of expanded criteria donor (ECD) kidneys and kidney donor profile index (KDPI) > 85% kidneys represents a significant initiative in addressing this shortage. Our study aimed to investigate the clinical outcomes of kidney transplantation by the ECD and KDPI > 85% kidneys, as well as the risk factors influencing graft survival, with the aim of providing a reference for the clinical application of the ECD and KDPI > 85% kidneys in Chinese population.
Methods
This retrospective analysis included 326 adult donor kidney transplant recipients from July 2018 to June 2020. The donor kidneys were classified into ECD kidneys (n = 110) and standard criteria donor (SCD) kidneys (n = 216) based on the United Network for Organ Sharing (UNOS) criteria, as well as into kidneys with KDPI > 85% (n = 42) and KDPI ≤ 85% (n = 284), according to the donor’s KDPI value. T tests, chi-square tests, and Mann-Whitney U tests were used to compare complications and renal function following kidney transplantation. Additionally, the log-rank test was used to assess differences in survival rates, whereas Cox regression analysis was conducted to identify risk factors associated with graft loss.
Results
Analysis revealed that grafts from ECDs exhibited significantly poorer survival rates (P = 0.004), whereas the survival rates of their recipients were comparable (P = 0.710). No significant differences were observed between the ECD and SCD groups regarding the incidence of DGF (22.7% vs. 26.4%, respectively; P = 0.471) or AR (24.5% vs. 25.9%, respectively; P = 0.787). At 3 months, 6 months, 1 year, 2 years, 3 years, and 4 years posttransplantation, the SCr level and eGFR in the ECD group were significantly lower than those in the SCD group (all P < 0.05); however, no differences were noted at 1 month posttransplantation. Furthermore, the SCr level and eGFR in the kidneys of patients with a KDPI > 85% were significantly worse than those in the kidneys of patients with a KDPI ≤ 85% at 6 months, 2 years, 3 years, and 4 years posttransplantation (all P < 0.05), with no differences being observed at 1 month, 3 months, and 1 year posttransplantation. Additionally, no significant differences were observed between the KDPI > 85% and KDPI ≤ 85% groups regarding the incidence of DGF, AR, graft survival, or recipient survival (all P > 0.05). Multivariate Cox regression analysis indicated that ECD kidneys (HR = 3.647, P = 0.003) and AR (HR = 4.675, P < 0.001) were independent risk factors for graft loss.
Conclusion
In this validation study of the transplant scoring criteria based on the Chinese population, our study indicated that compared with SCD kidneys, ECD kidneys demonstrated poorer graft survival and a tendency towards inferior postoperative renal function. However, the rates of recipient survival, DGF, and AR were comparable. Additionally, graft and recipient survival, as well as the incidence of DGF and AR, in KDPI > 85% kidneys were also similar to those in KDPI ≤ 85% kidneys. Nevertheless, kidneys with a KDPI > 85% tended to exhibit inferior postoperative renal function. Thus, the KDPI score is a valuable tool for predicting graft function in Chinese population.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer




